Gyeonggi-do, South Korea

Kwang-Soon Shin

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kwang-Soon Shin: Innovator in Pharmaceutical Composition

Introduction

Kwang-Soon Shin is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of inflammatory bowel disease. His innovative work has led to the development of a unique pharmaceutical composition that addresses this medical condition.

Latest Patents

Kwang-Soon Shin holds 1 patent for his invention titled "Pharmaceutical composition containing fraction, and preparation method thereof." This patent relates to a pharmaceutical composition designed for preventing, treating, or ameliorating inflammatory bowel disease. The active ingredient in this composition is a specific solvent fraction obtained through a defined preparation method.

Career Highlights

Throughout his career, Kwang-Soon Shin has worked with various organizations that have allowed him to advance his research and innovations. Notably, he has been associated with Pharmacobio, Inc. and the Kyonggi University Industry & Academia Cooperation Foundation. His work in these institutions has contributed to the development of effective pharmaceutical solutions.

Collaborations

Kwang-Soon Shin has collaborated with several professionals in his field, including Yang-Kook Rho. These collaborations have enhanced his research and have been instrumental in the advancement of his inventions.

Conclusion

Kwang-Soon Shin is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of inflammatory bowel disease. His innovative approach and dedication to research continue to inspire advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…